Your PCOS Diagnosis and the Pill: What Your Doctor May Not Have Told You

This article is for educational purposes and does not replace medical advice. Any changes to your treatment should be discussed with your doctor.

If you have been diagnosed with Polycystic Ovary Syndrome, there is a good chance the first thing you were offered was the pill. For many women, it was presented not as one option among several, but as the option, often without a clear explanation of how it works or what it does not do.

This article is not an argument against medical treatment. It is an explanation of what the pill actually does in the context of PCOS, and what it does not.

What PCOS Is

Polycystic Ovary Syndrome affects an estimated 8–13% of women of reproductive age worldwide, depending on diagnostic criteria used, making it one of the most common hormonal conditions in women (Bozdag et al., Human Reproduction Update, 2016; Teede et al., International PCOS Guidelines, 2023).

The core features are irregular or absent ovulation, elevated androgens (hormones like testosterone), and the presence of multiple small follicles on the ovaries visible on ultrasound. These produce a range of symptoms: irregular cycles, acne, excess hair growth, weight changes, and difficulty conceiving.

What the Pill Does, and Does Not Do

Hormonal contraceptives manage PCOS symptoms through a specific mechanism: they suppress the natural cycle. By reducing LH and FSH, they prevent ovulation. The ovaries become hormonally quieter. Androgen levels often reduce, partly because the pill increases SHBG, the protein that binds and neutralises free androgens.

The result: symptoms often improve. Cycles become predictable. Acne may clear. This is real, and for many women it is genuinely helpful.

What the pill does not do is address the underlying causes of PCOS. It manages the hormonal output without changing what is driving the condition. When the pill is stopped, particularly for women who want to conceive using the Fertility Awareness Method, the original condition remains, often accompanied by a temporary disruption of cycle function as the body re-establishes its own hormonal patterns.

Understanding PCOS: Contributing Factors, Not Fixed Types

PCOS is a heterogeneous condition, the underlying mechanisms vary significantly between women, and this matters for how it is best managed. Rather than fixed, mutually exclusive "types," it is more accurate to think in terms of contributing factors:

Insulin resistance: the most common underlying driver, present in approximately 50–70% of women with PCOS regardless of body weight (DeUgarte et al., 2005; Dunaif, 1997). Elevated insulin stimulates androgen production in the ovaries. Addressing insulin sensitivity through diet and exercise can directly reduce androgen levels and support ovulation.

Chronic low-grade inflammation: inflammation is a recognised contributing factor that stimulates androgen production. Anti-inflammatory nutrition and stress management are relevant levers, though this is not a separate "type" of PCOS.

Adrenal androgen contribution: some women with PCOS have elevated DHEAS (an adrenal androgen) rather than primarily ovarian androgens. Stress management and adrenal support may be relevant in these cases.

Post-pill cycle disruption: it is worth noting that some women experience temporary cycle irregularities after stopping hormonal contraception, which can briefly mimic PCOS on hormone tests. This is a distinct, transient phenomenon, not a form of PCOS itself. If tests are taken within the first few months after stopping the pill, results may not reflect the underlying baseline.

A pill prescription addresses the androgen symptoms across all of these presentations. It does not change the underlying contributing mechanism in any of them.

The Insulin Question

For the majority of women with PCOS, particularly those in whom insulin resistance is a significant contributing factor, there is a meaningful question about whether hormonal contraception may affect the underlying cause.

Some studies have observed changes in markers of insulin sensitivity within months of starting hormonal contraception, though the evidence is mixed and depends significantly on formulation (Amiri et al., systematic review, 2020). The 2023 international PCOS guidelines (Teede et al.) still recommend combined oral contraceptives as a first-line option for managing PCOS symptoms, while noting that metabolic markers should be monitored in those with metabolic risk factors.

If insulin resistance is a significant driver of your PCOS, this is a conversation worth having with a doctor who is looking at the full picture, not a reason to stop treatment without supervision.

What Else Has Been Tried

Lifestyle intervention is recommended as first-line management for PCOS alongside or before pharmacological treatment (Teede et al., 2018/2023). Structured programmes addressing diet, exercise, and stress management have shown improvements in cycle regularity in many women with PCOS. Some intensive clinical studies, typically supervised programmes of 6–12 months targeting women with metabolic risk factors, have reported ovulation restoration in a majority of participants, though results vary significantly depending on PCOS presentation, starting metabolic profile, and programme intensity.

These programmes typically combine: dietary changes targeting insulin sensitivity, nutritional supplementation addressing documented deficiencies, stress management, and regular cycle tracking. The tracking element is important — FAM charting allows a woman to see whether ovulation is returning, and when, giving both her and her practitioner objective data.

How to Use This Information

This is not a recommendation to stop any treatment without medical supervision. If you are on the pill for PCOS management and it is working for you, that is a valid situation.

What this article offers is a framework for a more complete conversation with your doctor:

• Ask whether insulin resistance has been assessed (fasting insulin or HOMA-IR)
• Ask which contributing factors are most relevant to your presentation
• Ask what the plan is for addressing root causes alongside symptom management
• If you want to stop the pill (now or in future) ask about the transition and what to expect

You and your partner can review these questions together before your appointment. A PCOS diagnosis affects your fertility journey as a couple, understanding the underlying picture is useful for both of you.

If you want to use FAM for cycle awareness or fertility, understanding your specific PCOS picture will shape what your charts will look like and what patterns to expect.

One Next Step

Together with your partner, find your last blood test results and check whether insulin or HOMA-IR was included. If it was not tested, that is worth raising with your GP at your next appointment.

---

Source: NatProFam.pl — Monika Dowejko. Adapted for FertilityFlow with Guide By Hand voice. Attribution required on publication. FE second review required before publish.